Research/development, approval and marketing of medicine and test reagents for major public health events: a comparison between China and foreign countries

The epidemic of coronavirus disease 2019 is a severe test for China′s response to major public health emergencies. Through literature reviews, we summarized approval system and process for research/development and marketing of medicine and test reagents related to responses to major public health emergencies in many foreign countries and conducted comparative studies on the system and process at home and abroad for providing references to relevant system construction and administrative management China.